Castleman’s disease in the rheumatological practice
2024

Castleman’s Disease in Rheumatological Practice

Sample size: 79 publication Evidence: moderate

Author Information

Author(s): Moritz Schmalzing, Sander O., Seidl M., Marks R., Blank N., Kötter I., Tiemann M., Backhaus M., Manger B., Hübel K., Müller-Ladner U., Henes J.

Primary Institution: Universitätsklinikum Würzburg

Hypothesis

The study investigates the challenges in diagnosing Castleman’s disease due to its heterogeneous clinical symptoms.

Conclusion

Castleman’s disease is often misdiagnosed due to its overlapping symptoms with other diseases, and immediate treatment is crucial for the potentially life-threatening idiopathic multicentric form.

Supporting Evidence

  • Castleman’s disease can be misdiagnosed due to its symptoms overlapping with other diseases.
  • Immediate treatment is necessary for idiopathic multicentric Castleman’s disease as it can be life-threatening.
  • Histological examination is crucial for accurate diagnosis of Castleman’s disease.

Takeaway

Castleman’s disease can look like other illnesses, making it hard to spot, but it's important to treat it quickly because it can be very serious.

Methodology

The study includes case reports and discusses the clinical presentation, diagnosis, and treatment of Castleman’s disease.

Limitations

The rarity of the disease leads to limited data on its frequency and may result in underdiagnosis.

Participant Demographics

The median age at diagnosis for multicentric Castleman’s disease is in the fifth to sixth decade of life, and it tends to affect men more often than women.

Digital Object Identifier (DOI)

10.1007/s00393-024-01560-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication